Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases
- Autores
- Carrera Silva, Eugenio Antonio; Puyssegur, Juliana; Errasti, Andrea Emilse
- Año de publicación
- 2025
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The gut biome, a complex ecosystem of micro- and macro-organisms, plays a crucial role in human health. A disruption in this evolutive balance, particularly during early life, can lead to immune dysregulation and inflammatory disorders. ‘Biome repletion’ has emerged as a potential therapeutic approach, introducing live microbes or helminth-derived products to restore immune balance. While helminth therapy has shown some promise, significant challenges remain in optimizing clinical trials. Factors such as patient genetics, disease status, helminth species, and the optimal timing and dosage of their products or metabolites must be carefully considered to train the immune system effectively. We aim to discuss how helminths and their products induce trained immunity as prospective to treat inflammatory and autoimmune diseases. The molecular repertoire of helminth excretory/secretory products (ESPs), which includes proteins, peptides, lipids, and RNA-carrying extracellular vesicles (EVs), underscores their potential to modulate innate immune cells and hematopoietic stem cell precursors. Mimicking natural delivery mechanisms like synthetic exosomes could revolutionize EV-based therapies and optimizing production and delivery of ESP will be crucial for their translation into clinical applications. By deciphering and harnessing helminth-derived products’ diverse modes of action, we can unleash their full therapeutic potential and pave the way for innovative treatments.
Fil: Carrera Silva, Eugenio Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Puyssegur, Juliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Errasti, Andrea Emilse. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
Trained immunity
Helminth and microbiome
Inflammatory diseases and autoimmunity
Extracelular vesicles and ESP - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/273560
Ver los metadatos del registro completo
| id |
CONICETDig_4f077de3cad08dfb8dfb7692321b9891 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/273560 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseasesCarrera Silva, Eugenio AntonioPuyssegur, JulianaErrasti, Andrea EmilseTrained immunityHelminth and microbiomeInflammatory diseases and autoimmunityExtracelular vesicles and ESPhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The gut biome, a complex ecosystem of micro- and macro-organisms, plays a crucial role in human health. A disruption in this evolutive balance, particularly during early life, can lead to immune dysregulation and inflammatory disorders. ‘Biome repletion’ has emerged as a potential therapeutic approach, introducing live microbes or helminth-derived products to restore immune balance. While helminth therapy has shown some promise, significant challenges remain in optimizing clinical trials. Factors such as patient genetics, disease status, helminth species, and the optimal timing and dosage of their products or metabolites must be carefully considered to train the immune system effectively. We aim to discuss how helminths and their products induce trained immunity as prospective to treat inflammatory and autoimmune diseases. The molecular repertoire of helminth excretory/secretory products (ESPs), which includes proteins, peptides, lipids, and RNA-carrying extracellular vesicles (EVs), underscores their potential to modulate innate immune cells and hematopoietic stem cell precursors. Mimicking natural delivery mechanisms like synthetic exosomes could revolutionize EV-based therapies and optimizing production and delivery of ESP will be crucial for their translation into clinical applications. By deciphering and harnessing helminth-derived products’ diverse modes of action, we can unleash their full therapeutic potential and pave the way for innovative treatments.Fil: Carrera Silva, Eugenio Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Puyssegur, Juliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Errasti, Andrea Emilse. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaeLife Sciences Publications Ltd2025-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/273560Carrera Silva, Eugenio Antonio; Puyssegur, Juliana; Errasti, Andrea Emilse; Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases; eLife Sciences Publications Ltd; eLife; 14; 4-2025; 1-222050-084XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://elifesciences.org/articles/105393info:eu-repo/semantics/altIdentifier/doi/10.7554/eLife.105393info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-11-05T10:24:02Zoai:ri.conicet.gov.ar:11336/273560instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-11-05 10:24:03.043CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases |
| title |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases |
| spellingShingle |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases Carrera Silva, Eugenio Antonio Trained immunity Helminth and microbiome Inflammatory diseases and autoimmunity Extracelular vesicles and ESP |
| title_short |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases |
| title_full |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases |
| title_fullStr |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases |
| title_full_unstemmed |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases |
| title_sort |
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases |
| dc.creator.none.fl_str_mv |
Carrera Silva, Eugenio Antonio Puyssegur, Juliana Errasti, Andrea Emilse |
| author |
Carrera Silva, Eugenio Antonio |
| author_facet |
Carrera Silva, Eugenio Antonio Puyssegur, Juliana Errasti, Andrea Emilse |
| author_role |
author |
| author2 |
Puyssegur, Juliana Errasti, Andrea Emilse |
| author2_role |
author author |
| dc.subject.none.fl_str_mv |
Trained immunity Helminth and microbiome Inflammatory diseases and autoimmunity Extracelular vesicles and ESP |
| topic |
Trained immunity Helminth and microbiome Inflammatory diseases and autoimmunity Extracelular vesicles and ESP |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
The gut biome, a complex ecosystem of micro- and macro-organisms, plays a crucial role in human health. A disruption in this evolutive balance, particularly during early life, can lead to immune dysregulation and inflammatory disorders. ‘Biome repletion’ has emerged as a potential therapeutic approach, introducing live microbes or helminth-derived products to restore immune balance. While helminth therapy has shown some promise, significant challenges remain in optimizing clinical trials. Factors such as patient genetics, disease status, helminth species, and the optimal timing and dosage of their products or metabolites must be carefully considered to train the immune system effectively. We aim to discuss how helminths and their products induce trained immunity as prospective to treat inflammatory and autoimmune diseases. The molecular repertoire of helminth excretory/secretory products (ESPs), which includes proteins, peptides, lipids, and RNA-carrying extracellular vesicles (EVs), underscores their potential to modulate innate immune cells and hematopoietic stem cell precursors. Mimicking natural delivery mechanisms like synthetic exosomes could revolutionize EV-based therapies and optimizing production and delivery of ESP will be crucial for their translation into clinical applications. By deciphering and harnessing helminth-derived products’ diverse modes of action, we can unleash their full therapeutic potential and pave the way for innovative treatments. Fil: Carrera Silva, Eugenio Antonio. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Puyssegur, Juliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Errasti, Andrea Emilse. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
| description |
The gut biome, a complex ecosystem of micro- and macro-organisms, plays a crucial role in human health. A disruption in this evolutive balance, particularly during early life, can lead to immune dysregulation and inflammatory disorders. ‘Biome repletion’ has emerged as a potential therapeutic approach, introducing live microbes or helminth-derived products to restore immune balance. While helminth therapy has shown some promise, significant challenges remain in optimizing clinical trials. Factors such as patient genetics, disease status, helminth species, and the optimal timing and dosage of their products or metabolites must be carefully considered to train the immune system effectively. We aim to discuss how helminths and their products induce trained immunity as prospective to treat inflammatory and autoimmune diseases. The molecular repertoire of helminth excretory/secretory products (ESPs), which includes proteins, peptides, lipids, and RNA-carrying extracellular vesicles (EVs), underscores their potential to modulate innate immune cells and hematopoietic stem cell precursors. Mimicking natural delivery mechanisms like synthetic exosomes could revolutionize EV-based therapies and optimizing production and delivery of ESP will be crucial for their translation into clinical applications. By deciphering and harnessing helminth-derived products’ diverse modes of action, we can unleash their full therapeutic potential and pave the way for innovative treatments. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025-04 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/273560 Carrera Silva, Eugenio Antonio; Puyssegur, Juliana; Errasti, Andrea Emilse; Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases; eLife Sciences Publications Ltd; eLife; 14; 4-2025; 1-22 2050-084X CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/273560 |
| identifier_str_mv |
Carrera Silva, Eugenio Antonio; Puyssegur, Juliana; Errasti, Andrea Emilse; Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases; eLife Sciences Publications Ltd; eLife; 14; 4-2025; 1-22 2050-084X CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://elifesciences.org/articles/105393 info:eu-repo/semantics/altIdentifier/doi/10.7554/eLife.105393 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
eLife Sciences Publications Ltd |
| publisher.none.fl_str_mv |
eLife Sciences Publications Ltd |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1847977869002670080 |
| score |
13.087074 |